BGT Antibodies

Santa Cruz Biotechnology provides a broad selection of BGT Antibodies for research applications. BGT Antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BGT, or Brain Glucose Transporter, plays a crucial role in the transport of glucose across the blood-brain barrier, ensuring that the brain receives the necessary energy supply for optimal function. BGT is essential for maintaining neuronal health and is implicated in various neurological disorders, making it a significant target for research in neurobiology and metabolic diseases. Understanding the function and regulation of BGT can provide insights into therapeutic strategies for conditions such as Alzheimer's disease and other cognitive impairments. Researchers studying glucose transport mechanisms in the brain can utilize BGT monoclonal antibodies to examine protein expression, localization, and interactions. BGT monoclonal antibodies enable detailed investigation of glucose transport pathways and their relationship to neurological conditions. Santa Cruz Biotechnology monoclonal antibodies for BGT support researchers worldwide in advancing our understanding of brain glucose metabolism and potential therapeutic interventions.